These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38238175)
1. Efficacy and safety of the modified Zhiwang decoction combined with methotrexate in early rheumatoid arthritis: study protocol for a randomised controlled trial. Zhang N; Zhang LB; Wang Z; Lan TY; Wang JP; Xiao C; Tao QW; Xu Y BMJ Open; 2024 Jan; 14(1):e076571. PubMed ID: 38238175 [TBL] [Abstract][Full Text] [Related]
2. Observation of the curative effect of Guizhi-Shaoyao-Zhimu decoction combined with methotrexate in the treatment of early rheumatoid arthritis based on ultrasonic evaluation: study protocol of a randomized, double-blind, controlled clinical trial. Shen J; Chen Q; Yang G; He Y Trials; 2021 Nov; 22(1):764. PubMed ID: 34732237 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the therapeutic efficacy of the Chinese herbal medicine Yishen Tongbi decoction in patients with active rheumatoid arthritis: protocol for a randomized, controlled, noninferiority trial. Zhao L; Li M; Xu Y; Liu L; Zhang M; Chen G Trials; 2019 Dec; 20(1):801. PubMed ID: 31888728 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Yishen Tongbi decoction versus methotrexate in patients with active rheumatoid arthritis: A double-blind, randomized, controlled, non-inferiority trial. Xu J; Zhang L; Xu Y; Yu J; Zhao L; Deng H; Li M; Zhang M; Lei X; Hu C; Jiao W; Dai Z; Liu L; Chen G Phytomedicine; 2023 Apr; 112():154704. PubMed ID: 36796186 [TBL] [Abstract][Full Text] [Related]
5. Effect of downregulation of serum MMP-3 levels by traditional Chinese medicine ingredients combined with methotrexate on the progression of bone injury in patients with rheumatoid arthritis: A protocol for a systematic review and meta-analysis. Sun Y; Huang Y; Chen T; Li X; Chen J; Wang Z; Lin K; Gao Y; He L Medicine (Baltimore); 2020 Oct; 99(43):e22841. PubMed ID: 33120813 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of the traditional Chinese medicine Jia Wei Niu Bang Zi granule combined with methotrexate in treating active rheumatoid arthritis: A multicenter, randomized, double-blinded controlled clinical trial. Wang YR; Liu L; Wang XY; Wang Q; Yao M; Cui XJ; Mao JC; Liu J; Gu XH; Chen YL; Yu X; Shi Q; Liang QQ; Wang YJ Medicine (Baltimore); 2019 Feb; 98(6):e14424. PubMed ID: 30732199 [TBL] [Abstract][Full Text] [Related]
7. [Treating rheumatoid arthritis patients of Shen deficiency and cold invading syndrome by bushen quhan zhiwang decoction combined methotrexate: an evaluation of clinical efficacy and safety]. Wang JM; Tao QW; Zhang YZ; Xu Y; Yan XP Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 May; 33(5):614-8. PubMed ID: 23905378 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Bi Qi Capsules in combination with methotrexate in the treatment of rheumatoid arthritis: A protocol of double-blind randomized controlled trial. Ding W; Chen S; Shi X; Zhao Y Medicine (Baltimore); 2021 May; 100(20):e25790. PubMed ID: 34011040 [TBL] [Abstract][Full Text] [Related]
9. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of the traditional Chinese medicine Juanbi pill combined with methotrexate in active rheumatoid arthritis: study protocol for a randomized controlled trial. Wang Q; Wang YR; Jia QY; Liu L; Xu CQ; Wang XY; Yao M; Cui XJ; Shi Q; Wang YJ; Liang QQ Trials; 2018 Mar; 19(1):188. PubMed ID: 29558967 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of Shenshi Qianghuo Dihuang Decoction in rheumatoid arthritis: a randomized controlled trial]. Chen ZW; Sun J; Li YM; Chen YQ Zhong Xi Yi Jie He Xue Bao; 2010 Jan; 8(1):35-9. PubMed ID: 20082756 [TBL] [Abstract][Full Text] [Related]
12. Real-world effects of Yishen Tongbi decoction for rheumatoid arthritis: protocol for a prospective, observational, multicenter cohort study with validation against double-blind, randomized, controlled trial. Liu L; Zhu F; Xin Y; Zhang L; Hu C; Xu Y; Zhang J; Liu L; Chen G Front Pharmacol; 2024; 15():1320578. PubMed ID: 38410132 [No Abstract] [Full Text] [Related]
14. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Brown S; Everett CC; Naraghi K; Davies C; Dawkins B; Hulme C; McCabe C; Pavitt S; Emery P; Sharples L; Buch MH Health Technol Assess; 2018 Jun; 22(34):1-280. PubMed ID: 29900829 [TBL] [Abstract][Full Text] [Related]
15. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW; Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial. Shimizu T; Kawashiri SY; Morimoto S; Kawazoe Y; Kuroda S; Kawasaki R; Ito Y; Kiya R; Sato S; Yamamoto H; Kawakami A Trials; 2023 Mar; 24(1):161. PubMed ID: 36869356 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy. Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC Int J Rheum Dis; 2016 Nov; 19(11):1143-1156. PubMed ID: 26259617 [TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial. Lee S; Cho Y; Kim J; Kang JW; Yoon GY; Lee JH; Jung SY; Kwon O; Shin KM; Lee JD Trials; 2018 Sep; 19(1):471. PubMed ID: 30176923 [TBL] [Abstract][Full Text] [Related]
19. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study. Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME Ann Rheum Dis; 2017 Jan; 76(1):96-104. PubMed ID: 27165179 [TBL] [Abstract][Full Text] [Related]
20. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]